These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10328251

  • 1. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.
    Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T.
    Arch Neurol; 1999 May; 56(5):563-8. PubMed ID: 10328251
    [Abstract] [Full Text] [Related]

  • 2. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.
    Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T.
    Arch Neurol; 2000 Jul; 57(7):1040-4. PubMed ID: 10891987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Visual function in Huntington's disease patients and presymptomatic gene carriers.
    O'Donnell BF, Wilt MA, Hake AM, Stout JC, Kirkwood SC, Foroud T.
    Mov Disord; 2003 Sep; 18(9):1027-34. PubMed ID: 14502670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease.
    Maroof DA, Gross AL, Brandt J.
    J Clin Exp Neuropsychol; 2011 Oct; 33(8):901-9. PubMed ID: 21644140
    [Abstract] [Full Text] [Related]

  • 9. Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers.
    Farrow M, Chua P, Churchyard A, Bradshaw JL, Chiu E, Georgiou-Karistianis N.
    Cogn Behav Neurol; 2006 Dec; 19(4):208-16. PubMed ID: 17159618
    [Abstract] [Full Text] [Related]

  • 10. Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease.
    de Boo GM, Tibben A, Lanser JB, Jennekens-Schinkel A, Hermans J, Maat-Kievit A, Roos RA.
    Arch Neurol; 1997 Nov; 54(11):1353-7. PubMed ID: 9362982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.
    Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R.
    Acta Neurol Scand; 2002 Sep; 106(3):131-41. PubMed ID: 12174172
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
    Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D.
    Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
    [Abstract] [Full Text] [Related]

  • 19. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
    Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ, Track-HD and Track-On Investigators.
    JAMA Neurol; 2017 Nov 01; 74(11):1352-1360. PubMed ID: 28975278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.